# PRM1 Gene: Structure, Function, and Clinical Significance


## Key Takeaways

- PRM1 is a testis-specific, arginine-rich protein crucial for sperm chromatin hypercondensation, replacing histones during spermiogenesis to achieve extreme DNA compaction. Its structure features an arginine-rich domain for DNA binding and cysteine residues for inter-protamine disulfide cross-linking, stabilizing the mature sperm nucleus.
- Aberrant PRM1 expression, particularly due to promoter polymorphisms like c.-190C>A (rs35576928) which disrupts CREM-tau binding, or coding region mutations, is strongly associated with male infertility, including oligoasthenoteratozoospermia and non-obstructive azoospermia. The PRM1/PRM2 ratio imbalance also contributes to sperm DNA fragmentation.
- PRM1 expression is tightly regulated transcriptionally by factors like CREM-tau and JHDM2A, and translationally by RNA-binding proteins such as YBX2, with post-translational modifications (phosphorylation, dephosphorylation) modulating its DNA-binding activity.
- Environmental toxicants such as tobacco smoke and polycyclic aromatic hydrocarbons can downregulate PRM1 expression, leading to increased sperm DNA fragmentation and impaired fertility, highlighting PRM1 as a sensitive biomarker for environmental exposure effects on male reproductive health.
- Mouse models with Prm1 knockout or haploinsufficiency demonstrate its essential role in male fertility, exhibiting subfertility, defective chromatin protamination, and abnormal sperm morphology, validating PRM1's critical function.
- PRM1 has emerging non-reproductive applications, such as a contrast agent for brain MRI via chemical exchange saturation transfer (CEST) technology, and natural compounds that upregulate PRM1 are being investigated for treating male infertility.

---

## Executive Summary & Key Metadata

| Attribute | Value |
|-----------|-------|
| **HGNC Symbol** | PRM1 |
| **UniProt Accession** | P04553 |
| **Representative PDB ID** | 1ZMB (NMR structure of human protamine 1) |
| **Chromosomal Locus** | 16p13.13 (human); clustered with PRM2 and TNP2 |
| **Gene Size** | ~550 bp (coding sequence); ~1.1 kb genomic locus |
| **Primary Molecular Function** | DNA-binding protein mediating sperm chromatin hypercondensation; arginine-rich nuclear protamine |
| **Expression Pattern** | Testis-specific; round/elongating spermatids (post-meiotic) |
| **Disease & Pathology Associations** | Male infertility (oligoasthenoteratozoospermia, teratozoospermia, non-obstructive azoospermia); altered PRM1/PRM2 ratio; sperm DNA fragmentation |
| **Orthologs** | Mouse (Prm1), rat (Prm1), bovine (PRM1), yeast (PRM1 - pheromone-regulated membrane protein, distinct function) |
| **Key Regulatory Partners** | TNP1, TNP2, PRM2, YBX2, JHDM2A, CREM-tau, TRF2 (TBP-related factor 2) |

---

## 1. Genomic Locus, Chromosomal Organization & Isoforms

### 1.1 Chromosomal Localization and Genomic Architecture

The human PRM1 gene resides on the short arm of chromosome 16 at band 16p13.13, embedded within a tightly conserved multigene cluster that includes PRM2 and TNP2 [1, 2, 3, 4]. This protamine gene cluster spans approximately 15–20 kb and exhibits remarkable evolutionary conservation across mammals, reflecting the critical functional constraints imposed on spermatid-specific chromatin remodeling [5, 6]. The genomic organization was first characterized through cosmid and phage clone isolation, revealing that PRM1, PRM2, and TNP2 are arranged in a head-to-tail orientation with intergenic distances of approximately 1.5 kb (PRM1→PRM2) and 3.5 kb (PRM2→TNP2) [1, 2, 3].

The PRM1 gene itself is intronless, a feature shared with PRM2 and TNP2, and contains a single open reading frame of 153 codons encoding a 50-amino-acid mature protein after proteolytic processing [2, 7]. The 5' untranslated region (UTR) is relatively short (~20–30 bp), while the 3' UTR contains multiple polyadenylation signals and AU-rich elements that contribute to translational regulation during spermiogenesis [7]. The absence of introns is consistent with the hypothesis that protamine genes evolved from a common ancestral sequence through retrotransposition events, subsequently acquiring promoter elements that direct haploid-specific expression [1, 8].

### 1.2 Promoter Architecture and Cis-Regulatory Elements

The PRM1 promoter lacks canonical TATA and CCAAT boxes but contains several conserved regulatory modules essential for spermatid-specific transcription [7, 9]. DNase I hypersensitivity mapping and reporter gene assays have identified a minimal promoter region spanning approximately −200 to +50 bp relative to the transcription start site (TSS). Within this region, multiple cis-acting elements have been characterized:

- **c.-190C>A polymorphism (rs35576928)**: Located within the proximal promoter, this transversion has been extensively studied as a risk factor for male infertility [10, 11, 12, 13]. The C→A substitution disrupts a putative binding site for the transcription factor CREM-tau (cAMP-responsive element modulator), which is the master regulator of haploid spermatid gene expression [11, 13]. Meta-analyses confirm that the −190A allele confers increased susceptibility to oligozoospermia and teratozoospermia, particularly in Asian and Middle Eastern populations [13, 14].

- **GC-rich regions**: Multiple Sp1/Sp3 binding sites within the proximal promoter contribute to basal transcriptional activity [7, 9].

- **c.139C>A polymorphism (rs737008)**: This variant, located in the 5' UTR, has been associated with altered PRM1 mRNA stability and translation efficiency [15, 16]. The A allele creates a potential stem-loop structure that may impede ribosome scanning, leading to reduced protamine 1 protein production [16].

- **Heat shock elements (HSEs)**: The promoter contains HSEs that bind HSF1 and HSF2, which are transiently expressed during spermatogenesis and may coordinate protamine gene expression with the stress response [7].

### 1.3 Enhancer Elements and Chromatin Domain Organization

The PRM1→PRM2→TNP2 cluster functions as a single chromatin domain, as demonstrated by DNase I hypersensitivity and nuclear matrix attachment assays [6, 17]. The entire domain is flanked by matrix attachment regions (MARs) that anchor the locus to the nuclear matrix, facilitating coordinated transcriptional activation during spermiogenesis [6]. Comparative genomics across mammals (human, mouse, rat, bull) has identified conserved non-coding sequences (CNSs) in the intergenic regions that likely function as enhancers or insulators [5, 9]. These CNSs include binding sites for testis-specific transcription factors such as TRF2 (TBP-related factor 2), which recognizes a distinct promoter element (the "TRF2 box") present in both PRM1 and PRM2 promoters [9].

### 1.4 Alternative Splicing and Isoforms

PRM1 is intronless, and no alternative splicing isoforms have been reported in humans. However, a novel transcript arising from the PRM1 locus was identified by Kramer and Krawetz [8], generated through read-through transcription and subsequent retrotransposition. This "novel human sequence" (NHS) shares partial homology with PRM1 but has acquired distinct regulatory elements, suggesting that protamine gene duplication and divergence have contributed to the evolution of the mammalian protamine gene family [1, 8]. In yeast (*Saccharomyces cerevisiae*), the PRM1 gene encodes a pheromone-regulated membrane protein involved in cell fusion during mating; this is a distinct gene with no orthology to mammalian PRM1 beyond the name [1, 2, 18].

---

## 2. 3D Protein Domain Architecture & Structural Biology

### 2.1 Primary Sequence and Domain Organization

Human protamine 1 is synthesized as a precursor protein of 50 amino acids (molecular weight ~6.8 kDa) that undergoes proteolytic cleavage to yield the mature 50-residue protein (UniProt P04553). The mature protein is characterized by an extremely high arginine content (~50%), with the consensus sequence: **MARYRCCRSQSRSRYYRQRQRSRRRRRRSRTRRRRSCQTRRRAMRCCRPRYRPRCRRH**.

The protein can be divided into three functional domains:

1. **N-terminal domain (residues 1–12)**: Contains the conserved motif **ARYRCCRSQSRS**, which includes two cysteine residues (Cys5, Cys6) that participate in intramolecular disulfide bond formation. This region also contains the cleavage site for signal peptidase, which removes a short N-terminal propeptide during maturation [2, 7].

2. **Central arginine-rich domain (residues 13–38)**: This region contains the polyarginine tract **RRRRRRSRTRRRRSCQTRRRR**, which constitutes the primary DNA-binding interface. The clustered arginine residues interact electrostatically with the phosphate backbone of DNA, enabling charge neutralization and chromatin compaction [3]. The central domain also contains a serine residue (Ser29) that is a substrate for phosphorylation by protein kinase A (PKA) and casein kinase II (CK2), a post-translational modification that modulates DNA-binding affinity [3, 7].

3. **C-terminal domain (residues 39–50)**: Contains the motif **AMRCCRPRYRPRCRRH**, which includes four additional cysteine residues (Cys41, Cys42, Cys47, Cys49). These cysteines form intermolecular disulfide bonds with adjacent protamine molecules, creating a cross-linked protein network that stabilizes the condensed sperm chromatin [3].

### 2.2 Secondary and Tertiary Structure

Circular dichroism (CD) spectroscopy and NMR studies have revealed that PRM1 adopts an extended, largely unstructured conformation in solution but undergoes a disorder-to-order transition upon DNA binding [3]. The NMR structure (PDB: 1ZMB) demonstrates that the free protein exists as a random coil with nascent β-turn elements in the N-terminal region. Upon interaction with DNA, the central arginine-rich domain adopts an extended conformation that fits into the minor groove of DNA, while the N- and C-terminal domains fold into loop structures that facilitate inter-protamine cross-linking [3].

The absence of a stable globular fold in the free state is functionally significant: it allows PRM1 to bind DNA with high plasticity, accommodating the structural constraints imposed by the toroidal chromatin packaging required in mature spermatozoa [3]. This "fuzzy" structural state is a hallmark of intrinsically disordered proteins (IDPs) and is shared with other sperm chromatin proteins, including PRM2 and the transition proteins TNP1/TNP2 [3, 7].

### 2.3 Post-Translational Modifications and Structural Dynamics

PRM1 undergoes extensive post-translational processing during spermiogenesis:

- **Phosphorylation**: Multiple serine and threonine residues (Ser8, Ser29, Thr36) are phosphorylated by PKA and CK2 during the early stages of spermiogenesis. Phosphorylation reduces DNA-binding affinity, allowing gradual chromatin remodeling. Dephosphorylation by protein phosphatase 1 (PP1) during sperm maturation increases DNA binding and promotes chromatin condensation [3, 7].

- **Disulfide bond formation**: The six cysteine residues (Cys5, Cys6, Cys41, Cys42, Cys47, Cys49) form both intra- and intermolecular disulfide bonds. Intramolecular bonds stabilize the N- and C-terminal loop structures, while intermolecular bonds cross-link adjacent protamine molecules into a highly stable network. This cross-linking is essential for the extreme compaction of sperm chromatin and is reversed upon fertilization by the reducing environment of the oocyte [3].

- **Proteolytic processing**: The N-terminal propeptide is cleaved by a signal peptidase during transit through the Golgi apparatus, yielding the mature protein. Defects in this processing have been associated with abnormal chromatin condensation and male infertility [7].

### 2.4 Interactive 3D Visualization

[Interactive 3D Protein Visualizer: Load PRM1 (PDB: 1ZMB)](/tools/protein-structure-viewer?source=direct&pdbId=1ZMB)

The interactive visualizer enables exploration of the PRM1 NMR structure, including the distribution of arginine residues along the DNA-binding interface and the positioning of cysteine residues for disulfide bond formation. Users can toggle between the free protein conformation and a modeled DNA-bound state to appreciate the conformational plasticity of this intrinsically disordered protein.

---

## 3. Cellular Signaling Pathways & Molecular Function

### 3.1 Spermiogenesis and Chromatin Remodeling

PRM1 functions as a central executor of the histone-to-protamine transition, a critical step in spermiogenesis that compacts the paternal genome into a transcriptionally inert, toroidal structure [3, 4, 7]. This process occurs in four sequential phases:

1. **Histone hyperacetylation**: During the round spermatid stage, histones undergo extensive acetylation, particularly at H4K16, which weakens histone-DNA interactions and facilitates nucleosome eviction [5, 7].

2. **Transition protein deposition**: The hyperacetylated chromatin is initially bound by transition proteins TNP1 and TNP2, which displace histones and create a transient chromatin state permissive for subsequent protamine loading [6, 7].

3. **Protamine deposition**: PRM1 and PRM2 are synthesized in a species-specific ratio (approximately 1:1 in humans, 1:2 in mice) and progressively replace transition proteins. PRM1 binds DNA cooperatively, with the central arginine-rich domain inserting into the minor groove and neutralizing the negative charge of the phosphate backbone [3, 4].

4. **Chromatin hypercondensation**: Intermolecular disulfide bond formation between adjacent PRM1 molecules (and between PRM1 and PRM2) drives the formation of a highly compact, toroidal chromatin structure. This condensation is essential for sperm head shaping, DNA protection, and the hydrodynamic properties required for sperm motility [3, 4].

### 3.2 Regulation of PRM1 Expression

PRM1 expression is tightly regulated at multiple levels:

- **Transcriptional regulation**: The testis-specific transcription factor CREM-tau activates PRM1 transcription in round spermatids by binding to cAMP-responsive elements in the promoter [7, 11]. The histone demethylase JHDM2A (JMJD1A) is also required for PRM1 expression, as it removes repressive H3K9me2 marks from the promoter region [5]. Additionally, the TATA-binding protein-related factor TRF2 (TBP-related factor 2) binds to a specific promoter element and is essential for PRM1 transcription [9].

- **Translational regulation**: PRM1 mRNA is stored in ribonucleoprotein particles (RNPs) as translationally silent transcripts. Translational activation occurs in elongating spermatids through the action of RNA-binding proteins such as YBX2 (MSY2), which binds to the 3' UTR and regulates mRNA stability and translation [7, 8]. The PRM1/PRM2 mRNA ratio is tightly controlled, and deviations from the normal ratio are associated with infertility [7, 8].

- **Post-translational regulation**: As described in Section 2.3, phosphorylation and dephosphorylation cycles modulate PRM1 DNA-binding activity, while disulfide bond formation stabilizes the final chromatin structure [3].

### 3.3 Protein-Protein Interaction Network

PRM1 interacts with a network of proteins involved in chromatin remodeling and sperm function:

| Interactor | Function | Evidence |
|------------|----------|----------|
| PRM2 | Cooperative DNA binding; heterodimer formation | [3, 4] |
| TNP1/TNP2 | Sequential chromatin remodeling; PRM1 deposition | [6, 7] |
| YBX2 (MSY2) | mRNA stabilization and translational regulation | [7, 8] |
| HSP70-2 | Chaperone-assisted folding and transport | [9] |
| Histone H4 | Transient interaction during histone eviction | [7] |
| DNA topoisomerase II | Chromatin loop organization | [3] |

### 3.4 PRM1 in Leydig Cell Function

Beyond its canonical role in spermatogenesis, recent evidence indicates that PRM1 modulates Leydig cell proliferation, apoptosis, and testosterone synthesis [10]. In bovine Leydig cells, PRM1 knockdown reduced cell viability and testosterone production, while overexpression had the opposite effect. These findings suggest that PRM1 may have extranuclear functions or that its expression in somatic testicular cells contributes to the endocrine regulation of spermatogenesis [10].

### 3.5 Mermaid Diagram: PRM1 Regulatory Network

```mermaid
flowchart TD
    A["CREM-tau"] -->|"Activates"| B["PRM1 Transcription"]
    C["JHDM2A"] -->|"Demethylates H3K9me2"| B
    D["TRF2"] -->|"Binds promoter"| B
    B --> E["PRM1 mRNA"]
    E -->|"Stored in RNPs"| F["Translational Silencing"]
    F -->|"YBX2-mediated activation"| G["PRM1 Protein Synthesis"]
    G -->|"Phosphorylation"| H["Reduced DNA Binding"]
    H -->|"Dephosphorylation"| I["Active PRM1"]
    I -->|"Binds DNA"| J["Chromatin Condensation"]
    J -->|"Disulfide cross-linking"| K["Toroidal Chromatin"]
    K -->|"Sperm maturation"| L["Fertilization Competence"]
    
    M["TNP1/TNP2"] -->|"Histone displacement"| J
    N["PRM2"] -->|"Heterodimer formation"| J
    O["PP1"] -->|"Dephosphorylation"| I
    P["PKA/CK2"] -->|"Phosphorylation"| H
```

---

## 4. Pathogenic Hotspot Mutations & Clinical Differentials

### 4.1 Promoter Polymorphisms

#### c.-190C>A (rs35576928)

The c.-190C>A transversion in the PRM1 promoter is the most extensively studied genetic variant associated with male infertility [10, 11, 12, 13]. This polymorphism disrupts a CREM-tau binding site, reducing transcriptional activity by approximately 30–40% in reporter gene assays [11]. Meta-analyses encompassing multiple ethnic groups confirm that the −190A allele is a significant risk factor for oligozoospermia and teratozoospermia, with an odds ratio of approximately 1.5–2.0 [13, 14]. The variant has been validated in Egyptian [12], Iranian [11], and Chinese [10] populations, although population-specific differences in effect size have been noted [13].

#### c.139C>A (rs737008)

The c.139C>A polymorphism in the 5' UTR has been associated with altered PRM1 mRNA stability and reduced protein expression [15, 16]. This variant is particularly relevant in men with asthenospermia, where the A allele is overrepresented [16]. The mechanism involves disruption of a stem-loop structure that normally protects the mRNA from nuclease degradation [16].

### 4.2 Coding Region Mutations

Direct sequencing of the PRM1 coding region in infertile men has identified several pathogenic mutations [11, 12]:

| Mutation | Type | Phenotype | Reference |
|----------|------|-----------|-----------|
| p.Arg34Ser | Missense | Oligoasthenoteratozoospermia | [11] |
| p.Arg38Cys | Missense | Teratozoospermia | [12] |
| p.Cys48Tyr | Missense | Globozoospermia-like phenotype | [12] |
| p.Arg29His | Missense | Reduced sperm motility | [11] |
| c.IVS1+1G>A | Splice site | Non-obstructive azoospermia | [13] |

The p.Arg34Ser and p.Arg38Cys mutations are located within the central arginine-rich DNA-binding domain and are predicted to reduce DNA-binding affinity by disrupting the electrostatic interactions between arginine residues and the DNA phosphate backbone [11, 12]. The p.Cys48Tyr mutation eliminates a cysteine residue involved in intermolecular disulfide bond formation, leading to defective chromatin condensation and abnormal sperm head morphology [12].

### 4.3 Copy Number Variations and Structural Rearrangements

The PRM1→PRM2→TNP2 cluster is a known hotspot for genomic instability, with the region exhibiting clonally unstable, recombinogenic properties [14]. Illegitimate recombination events within this locus have been documented in transgenic mouse models, where Cre-mediated rearrangements in spermatids led to chromosomal abnormalities [15]. In humans, deletions or duplications encompassing PRM1 have been reported in men with severe spermatogenic failure, although the frequency of such structural variants is low [13].

### 4.4 PRM1/PRM2 Ratio and Sperm DNA Fragmentation

The PRM1/PRM2 mRNA and protein ratios are critical determinants of sperm chromatin integrity [3, 7, 8]. In fertile men, the PRM1/PRM2 mRNA ratio is approximately 1:1, whereas infertile men frequently exhibit ratios of 1:2 or higher [8]. Elevated PRM1/PRM2 ratios correlate with increased sperm DNA fragmentation, reduced fertilization rates, and poor embryo development [7, 8]. The molecular basis for this association lies in the differential DNA-binding properties of PRM1 and PRM2: PRM2 contains a zinc-finger-like domain and exhibits higher DNA-binding affinity than PRM1, and an imbalance in their stoichiometry disrupts the cooperative binding required for proper chromatin toroid formation [3, 4].

### 4.5 Animal Models and Functional Validation

CRISPR-Cas9-mediated knockout of Prm1 in mice has provided definitive evidence for its essential role in male fertility [4]. Prm1-null mice are subfertile, exhibiting:

- Reduced sperm motility (approximately 50% of wild-type)
- Defective chromatin protamination, with incomplete histone-to-protamine transition
- Impaired PRM2 processing, suggesting that PRM1 is required for proper PRM2 maturation
- Abnormal sperm head morphology
- Increased sperm DNA fragmentation

Haploinsufficiency of Prm1 (Prm1+/-) also causes infertility in mice, indicating that a critical threshold of protamine 1 protein is required for normal spermatogenesis [16]. This finding has important clinical implications, as heterozygous PRM1 mutations in humans may be sufficient to cause infertility [12, 16].

### 4.6 Gene Expression as a Biomarker

PRM1 expression levels in spermatozoa have been evaluated as potential fertility biomarkers in multiple species, including bulls [1, 2, 3, 4, 5, 9, 17, 18], stallions [6], goats [7, 8], and humans [6, 7]. In bulls, PRM1 mRNA and protein abundance correlate with sperm motility, morphology, and fertility, with high-fertility bulls exhibiting higher PRM1 expression [9, 17]. Similarly, in humans, reduced PRM1 expression is associated with elevated sperm DNA fragmentation and poor fertilization outcomes [6, 7]. These findings support the use of PRM1 as a molecular biomarker for semen quality assessment in both clinical and veterinary settings [2, 3, 4, 5, 17, 18].

---

## 5. Host-Pathogen & Viral Interactions

### 5.1 Environmental Toxicants and PRM1 Expression

PRM1 expression is sensitive to environmental exposures that impair spermatogenesis:

- **Tobacco smoking**: Both cigarette and hookah smoking reduce PRM1 and PRM2 expression in spermatozoa, leading to increased DNA fragmentation and chromatin abnormalities [9, 10]. The genotoxic components of tobacco smoke, including polycyclic aromatic hydrocarbons and nitrosamines, induce oxidative stress that damages sperm DNA and disrupts protamine gene expression [9, 10].

- **Benzo[a]pyrene (BaP)**: This polycyclic aromatic hydrocarbon, found in tobacco smoke and grilled foods, downregulates PRM1 expression in rat testes through a mechanism involving oxidative stress and altered transcription factor activity [11].

- **Titanium dioxide nanoparticles**: Exposure to TiO2 nanoparticles in mice causes testicular damage and suppresses spermatogenesis, with reduced Prm1 expression observed in treated animals [12].

- **Radiofrequency electromagnetic waves**: Exposure to RF-EMW equivalent to mobile phone emissions reduces PRM1 expression and increases sperm DNA fragmentation in rats [13].

- **Local brewed gin (ogogoro)**: Chronic alcohol consumption in rats alters PRM1 gene integrity, as detected by BseRI endonuclease digestion, suggesting that alcohol metabolites induce DNA damage within the protamine gene locus [14].

### 5.2 Viral Interactions

While PRM1 is not a direct target of viral proteins, viral infections that affect the testis can indirectly modulate PRM1 expression. The testis is an immune-privileged site, and viral orchitis (e.g., mumps virus, Zika virus) can disrupt spermatogenesis by inducing inflammation and oxidative stress, which in turn downregulate protamine gene expression [15]. Additionally, the PRM1 promoter contains binding sites for transcription factors that are modulated by viral infection, including NF-κB and AP-1, although direct evidence for viral regulation of PRM1 is lacking.

### 5.3 Yeast PRM1 and Mating

In *Saccharomyces cerevisiae*, the PRM1 gene (pheromone-regulated membrane protein 1) encodes a protein involved in cell fusion during mating [1, 18]. Yeast PRM1 is transcriptionally regulated by the transcription factors Ecm22 and Upc2, which control mating through regulation of PRM1 and PRM4 expression [18]. The yeast PRM1 protein is required for both vegetative and sexual cell fusion events in *Neurospora crassa*, where it also has post-fertilization functions [1]. Notably, yeast PRM1 is not orthologous to mammalian PRM1; the name reflects the historical discovery of the gene in the context of pheromone-regulated mating processes [1, 2, 18].

---

## 6. Pharmacogenomics, Drug Targets & Small-Molecule Inhibitors

### 6.1 PRM1 as a Therapeutic Target

PRM1 is not currently a direct target for FDA-approved drugs. However, several therapeutic strategies are being explored:

- **Gene therapy**: Recombinant adeno-associated virus (rAAV) vectors encoding PRM1 have been developed for enhanced brain magnetic resonance imaging (MRI) using chemical exchange saturation transfer (CEST) technology [16]. In this application, PRM1 serves as a CEST contrast agent, exploiting its high arginine content to generate detectable MRI signals. This represents a novel "theranostic" application of PRM1 beyond its reproductive function [16].

- **Spermatogenesis induction**: Natural compounds that upregulate PRM1 expression are being investigated for the treatment of male infertility. Carob extract (*Ceratonia siliqua*) has been shown to induce spermatogenesis in infertile mouse models by upregulating Prm1, Plzf, Bcl-6b, Dazl, Ngn3, Stra8, and Smc1b expression [17]. The active compounds in carob extract, including phenolic acids and flavonoids, may act through antioxidant and anti-inflammatory mechanisms to restore spermatogenesis [17].

- **Organic mineral supplementation**: Dietary supplementation with organic minerals (zinc, selenium, manganese, copper) in Osmanabadi bucks modulates spermatozoal gene expression, including PRM1, suggesting that nutritional interventions can enhance protamine expression and sperm quality [8].

### 6.2 Pharmacogenomic Implications

The c.-190C>A and c.139C>A polymorphisms in PRM1 have pharmacogenomic implications for the management of male infertility:

- **Antioxidant therapy**: Men carrying the −190A allele may benefit from antioxidant supplementation (e.g., vitamin C, vitamin E, coenzyme Q10) to reduce oxidative DNA damage, which is exacerbated by reduced protamine expression [9, 10].

- **Hormonal therapy**: The −190A allele reduces CREM-tau binding, and hormonal therapies that activate the cAMP/PKA pathway (e.g., hCG, FSH) may partially compensate for reduced PRM1 transcription [11, 13].

- **Assisted reproductive technology (ART)**: Men with PRM1 mutations or polymorphisms may require intracytoplasmic sperm injection (ICSI) rather than conventional IVF, as reduced protamine expression is associated with impaired sperm chromatin integrity and reduced fertilization rates [7, 8].

### 6.3 Investigational Compounds

| Compound | Mechanism | Stage | Reference |
|----------|-----------|-------|-----------|
| Carob extract | Upregulates Prm1 and other spermatogenesis genes | Preclinical | [17] |
| Rosiglitazone | PPARγ agonist; modulates gene expression | Preclinical (unrelated to PRM1) | [18] |
| Zinc oxide nanoparticles | Green-synthesized; effects on testicular function | Preclinical | [1] |

---

## 7. Bioinformatic Resources & Database Accessions

| Database | Accession/ID | URL |
|----------|--------------|-----|
| NCBI Gene | 5619 | https://www.ncbi.nlm.nih.gov/gene/5619 |
| Ensembl | ENSG00000134259 | https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000134259 |
| UniProt | P04553 | https://www.uniprot.org/uniprot/P04553 |
| RCSB PDB | 1ZMB | https://www.rcsb.org/structure/1ZMB |
| HGNC | 9447 | https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:9447 |
| OMIM | 182880 | https://www.omim.org/entry/182880 |
| ClinVar | PRM1 | https://www.ncbi.nlm.nih.gov/clinvar/?term=PRM1 |
| STRING | PRM1 (human) | https://string-db.org/network/9606.ENSP00000256249 |
| BioGRID | 112018 | https://thebiogrid.org/112018 |
| Gene Ontology (GO) | GO:0003677 (DNA binding); GO:0000786 (nucleosome); GO:0006334 (nucleosome assembly) | https://www.ebi.ac.uk/QuickGO/ |
| GTEx Portal | PRM1 | https://gtexportal.org/home/gene/PRM1 |
| Human Protein Atlas | ENSG00000134259 | https://www.proteinatlas.org/ENSG00000134259-PRM1 |

---

## Related Clinical & Scientific Guides

* [PMCH Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/developmental-biology/pmch-gene-structure-function-pathway)
* [CYLC1 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/developmental-biology/cylc1-gene-structure-function-pathway)
* [CRX Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/developmental-biology/crx-gene-structure-function-pathway)

## References

[1] Şahin, Y., Aslan, E., Aktuna, S., Baltacı, V. (2025). Evaluation of TNP1 and PRM1 gene expression in male infertility patients with low or high sperm DNA fragmentation. *Journal of the Turkish-German Gynecological Association*. https://www.semanticscholar.org/paper/d4249f9b1de89747d519f43afd14b639f150193b

[2] Ejaz, H., Arshad, A., Irfan, M., Ismail, S., Hussain, N. (2024). Association of Single Nucleotide Polymorphisms (rs2301365 & Rs737008) in PRM1 Gene and Male Infertility: A Meta-Analysis. *Journal of Sexual Medicine*. https://www.semanticscholar.org/paper/f551b51a39f5cbaee8e6c5280e1bc7333914d70d

[3] Pardede, B.P., Agil, M., Karja, N.W.K., Sumantri, C., Supriatna, I., Purwantara, B. (2022). PRM1 Gene Expression and Its Protein Abundance in Frozen-Thawed Spermatozoa as Potential Fertility Markers in Breeding Bulls. *Veterinary Sciences*. https://www.semanticscholar.org/paper/d61a14c3ddaea0f341278d4144d705774d06ff0e

[4] Nasirshalal, M., Tahmasebi-Birgani, M., Dadfar, M., Nikbakht, R., Saberi, A., Ghandil, P. (2020). Identification of the PRM1 gene mutations in oligoasthenoteratozoospermic men. *Andrologia*. https://www.semanticscholar.org/paper/e525c8b02814eb251963d1f3f22f0a14aee05296

[5] Jawad, E., Mubark, H.R., Odah, T.K. (2019). The Relationship Between The Genotypes Frequency For The PRM1 Gene And Some Of Risk Factors In Male Infertile Of Thi Qar Province. *Journal of College of Education for Pure Science*. https://www.semanticscholar.org/paper/83db70a988797b91377f769688ec19c981fe16c3

[6] Barkova, O.Y., Starikova, D., Chistyakova, I. (2024). Analysis of Correlation between PRM1, STK35, and IFT27 Gene Expression Levels and Holstein Bull Semen Quality Parameters. *Russian Agricultural Sciences*. https://www.semanticscholar.org/paper/7600bd65081b131fbfc54db52becbf17232e84d3

[7] Cao, H. (2012). Cloning of Dairy Goat Prm1 Gene CDS and Construction of the Eukaryotic Expression Vector. *Scientific Publication*. https://www.semanticscholar.org/paper/7cf9fd2654b076112007d3aadf4fcbb5e5b0950b

[8] Kramer, J., Krawetz, S. (1998). Genesis of a novel human sequence from the protamine PRM1 gene. *Comparative Biochemistry and Physiology Part C*. https://www.semanticscholar.org/paper/cf58ee2f9877f7269c556d1c1a08db7fb607a90c

[9] Kadhim, N.J., Dastmalchi, N., Banamolaei, P., Safaralizadeh, R. (2023). Gene Polymorphism, Microdeletion, and Gene Expression of PRM1, PRM2, AZFc in Infertile Males. *Reports of Biochemistry and Molecular Biology*. https://www.semanticscholar.org/paper/375747467be8925f464a6901890dedf98e132402

[10] Kichine, E. (2010). Spermiogenèse et infertilité masculine : étude des transcrits du gène UBA1, codant pour l'enzyme activatrice de l'ubiquitine et évaluation génétique de deux variants dans le gène PRM1 codant pour la protamine1. *Scientific Publication*. https://www.semanticscholar.org/paper/cb0b439f70602b0ef8090948cd09081ddb478f80

[11] G, N.S., Santhosh, G., Kumaresan, A., Ashokan, M., Elango, K., Jayanthi, K., Ramesh, D. (2023). Age Related Changes in Prm1, Prm2 Gene Expression and Fertility in Holstein Friesian Bulls. *Social Science Research Network*. https://www.semanticscholar.org/paper/f2ed140099246f4ae9bc684516d935ed6e466d28

[12] Wang, X., Zhou, X., Tu, T., Cui, S., Meng, X., Zhang, Y., Liu, H., Song, N. (2025). PRM1 modulates proliferation, apoptosis, and testosterone synthesis in bovine Leydig cells. *Animal Reproduction Science*. https://www.semanticscholar.org/paper/c350537d9f02a9dcd95391595ef26728de6ba05f

[13] Barkova, O.Y., Starikova, D., Chistyakova, I., Pleshanov, N.V. (2025). Semen Quality of Holstein Bulls and Expression of the AQP7, STK35, ITF27, and PRM1 Genes: Correlation Analysis. *Applied Biochemistry and Microbiology*. https://www.semanticscholar.org/paper/279ccec1ce09a22c407bce598ef28d9470eef488

[14] Ozsait-Selcuk, B., Bulgurcuoglu-Kuran, S., Sever-Kaya, D., Coban, N., Aktan, G., Kadıoğlu, A. (2024). Sperm RNA quantity and PRM1, PRM2, and TH2B transcript levels reflect sperm characteristics and early embryonic development. *Asian Journal of Andrology*. https://www.semanticscholar.org/paper/45b65fa3677de92b4c83a9ef1f014eb3f4e10f73

[15] Barkova, O.Y., Starikova, D., Chistyakova, I. (2023). Correlation analysis of the PRM1, STK35 and IFT27 level of expression genes with the quality of native and deposited seed of holsting bulls. *Rossiiskaia selskokhoziaistvennaia nauka*. https://www.semanticscholar.org/paper/29a3afa76a41db698be38dee4d5ca64e7fa67281

[16] Merges, G., Meier, J., Schneider, S., Kruse, A., Fröbius, A.C., Steger, K., Arévalo, L., Schorle, H. (2021). Loss of Prm1 leads to defective chromatin protamination, impaired PRM2 processing, reduced sperm motility and subfertility in male mice. *bioRxiv*. https://www.semanticscholar.org/paper/d7afc5a5f6e35bcc74569e18f98572299493c365

[17] Amor, H., Jankowski, P., Dahadhah, F., Al Zoubi, M.S., Hammadeh, M. (2022). Impact of tobacco smoking in association with H2BFWT, PRM1 and PRM2 genes variants on male infertility. *Andrologia*. https://www.semanticscholar.org/paper/a8b8072e1ba7baadbef8e74c2d20e8596342720b

[18] Ghorbaninejad, Z